Egalet Corporation has announced that the FDA has approved Arymo ER (morphine sulfate) extended-release (ER) tablets C-II for the management...
Egalet Corporation announced that the FDA has accepted the new drug application (NDA) for Arymo ER (morphine sulfate) extended-release tablets....
Pain Therapeutics announced two new publications for its drug candidate, Remoxy ER (extended-release oxycodone). The studies are published in Journal...
Osmotica Pharmaceutical announced that the FDA has approved Osmolex ER (amantadine HCl extended release), for the treatment of Parkinson's disease...
Teva Pharmaceutical has announced the FDA approved Vantrela ER (hydrocodone bitartrate) extended-release tablets [CII] formulated with Teva’s proprietary abuse deterrence...
Endo International plc continues to believe in the safety, efficacy, and favorable benefit-risk profile of Opana ER (oxymorphone hydrochloride extended...
The FDA has approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets) from Purdue Pharma, an extended-release/long-acting (ER/LA) opioid...
Collegium Pharmaceutical announced the publication of results from the Phase III clinical trial of Xtampza ER (oxycodone extended-release capsules). The...
Neos Therapeutics, Inc. announced that the FDA has approved Adzenys ER (amphetamine) Extended-Release Oral Suspension. Neos Therapeutics is the only...
The FDA has, on 25 October 2013, approved Zohydro ER (hydrocodone bitartrate extended-release capsules) from Zogenix, for the management of...